Alongside scientific innovation, ESMO 2025 emphasised the need for global collaboration in regulatory alignment and clinical ...

Medscape has joined the ranks of companies offering a generative AI chatbot to support clinical decision-making and help ease ...

Whilst there, pharmaphorum editor-in-chief Jonah Comstock and web editor Nicole Raleigh, together with Frontiers Health ...

Mosaic Therapeutics welcomes new CEO. Former Cimeio Therapeutics CEO Thomas Fuchs has taken the helm at Mosaic Therapeutics, ...

Bayer has billed Lynkuet as its next major pharma launch, saying it is due to start rolling out in the US later this month, ...

The approval puts Lunsumio on the same footing as Epkinly (epcoritamab) in FL – a form of non-Hodgkin lymphoma (NHL) – as ...

Shares in Agios Pharma lost nearly half their value in pre-market trading today after it posted mixed clinical results from a ...

Shortly after Alkermes and Avadel announced their deal, Lundbeck made an unsolicited offer of $23 per share, including $21 ...

At Frontiers Health 2025, we capturedoff-stage conversations with Renzo DiCarlo (AstraZeneca) and James Kugler (EMD Digital), ...

The commercialisation landscape in pharma is undergoing rapid transformation. At Frontiers Health 2025, we took the ...

At Veeva Commercial Summit 2025 in Madrid, web editor Nicole Raleigh sat down with Emma Hyland – Vice President, Commercial ...

China has such a dominant position in active pharmaceutical ingredient (API) production that there is a risk it could ...